Prokaryotics

Prokaryotics Inc. is an antibacterial discovery organization focused on developing innovative therapeutics to combat multidrug resistant bacteria and the global crisis of antibiotic resistance. The company, formed by former senior scientists from Merck & Co., Inc., has secured worldwide rights to develop and commercialize pre-clinical assets target... ing both Gram-negative and Gram-positive bacteria. Prokaryotics aims to leverage its expertise in bacterial physiology and medicinal chemistry to create new classes of antibiotics that target bacterial cell envelope assembly. Their programs are designed to address the urgent need for effective treatments against antibiotic-resistant infections.Read More